TransEnterix, Inc. logo

TransEnterix, Inc. (TRXDW)

Market Closed
OTC PINK OTC PINK
$
$
- Market Cap
- P/E Ratio
0% Div Yield
- Volume
-0.21 Eps
$
Previous Close
Day Range
0 0
Year Range
0 0

Summary

TRXDW is not paying dividends to its shareholders.
The stock of the company had never split.
The company's stock is traded on 0 different exchanges and in various currencies, with the primary listing on OTC PINK (USD).
Want to track TRXDW and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

TRXDW Chart

Chart

Empty chart
The chart has 2 Y axes displaying values, and values.
Loading, please wait...
End of interactive chart.

TransEnterix, Inc. (TRXDW) FAQ

What is the stock price today?

The current price is $0.00.

On which exchange is it traded?

TransEnterix, Inc. is listed on OTC PINK.

What is its stock symbol?

The ticker symbol is TRXDW.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, no market cap data is available.

Has TransEnterix, Inc. ever had a stock split?

No, there has never been a stock split.

TransEnterix, Inc. Profile

Medical Devices Industry
Healthcare Sector
Mr. Anthony Fernando CEO
OTC PINK Exchange
- ISIN
United States Country
207 Employees
- Last Dividend
- Last Split
12 Nov 1992 IPO Date

Overview

Asensus Surgical, Inc. is at the forefront of the medical device industry, focusing on the development and commercialization of robotics designed to enhance minimally invasive surgery (MIS). With operations spreading across the United States, Europe, the Middle East, Africa, and Asia, the company aims to revolutionize the way surgical procedures are performed. By digitizing the interface between surgeons and patients, Asensus Surgical facilitates performance-guided surgery, allowing surgeons to achieve improved outcomes for their patients. Originally known as TransEnterix, Inc., the company underwent a name change to Asensus Surgical, Inc. in February 2021, marking a new chapter in its mission to advance surgical technology. Its corporate headquarters are located in Durham, North Carolina.

Products and Services

The product portfolio of Asensus Surgical, Inc. is centered around the Senhance System and accompanying surgical tools and devices, which represent groundbreaking advancements in the field of robotic-assisted surgery:

  • Senhance System:

    This multi-port robotic surgery system empowers surgeons by providing up to four robotic arms that control various surgical instruments and a camera. Designed specifically for laparoscopic procedures, the Senhance System integrates seamlessly into existing hospital infrastructures, allowing for minimally invasive surgeries with precision and control unheard of with traditional manual techniques.

  • Instruments and Other Products:

    Asensus Surgical offers a range of specialized surgical instruments compatible with the Senhance System. These include instruments with a small diameter of 3mm and versatile hooks available in both 3mm and 5mm sizes. Additionally, the company provides articulating instruments that enhance the flexibility and reach of the robotic arms during procedures, enabling surgeons to perform complex maneuvers with ease.

  • Senhance Ultrasonic System:

    An advanced energy device, the Senhance ultrasonic system, is designed for surgical procedures requiring the ligation and division of tissue. It delivers controlled energy, allowing for precise cutting and coagulation, which are critical for minimizing intra-operative blood loss and improving surgical outcomes. This system complements the Senhance System, further extending the capabilities of robotic-assisted surgery.

Contact Information

Address: 1 TW Alexander Drive
Phone: 919 765 8400